Ophthalmological method can be used to monitor neurodegeneration in Parkinson’s patients

A study by the University of the Basque Country (UPV/EHU) and Biobizkaia proposes using an available, simple, non-invasive tool to monitor this neurodegeneration.

Catalyst licenses Santhera Pharmaceuticals’ vamorolone

Vamorolone has received orphan drug status in the US to treat Duchenne muscular dystrophy. Credit: StudioMolekuul / shutterstock.com. Santhera Pharmaceuticals and Catalyst Pharmaceuticals have signed

June 20, 2023

Commercial-stage manufacturing key for CDMOs as biotech funding pullback continues, Fujifilm Diosynth CEO says

On the back of reduced funding in early clinical-stage assets, CDMOs need to strengthen their commercial, large-scale manufacturing capabilities for 2024 in what looks like

November 10, 2023

Are step counts as effective as time-based exercise in boosting health?

Monitoring physical activity with either step counts or time spent exercising shows similar benefits in reducing cardiovascular disease and all-cause mortality among women in their

May 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.